GDNF/RET signaling in dopamine neurons in vivo

Cell Tissue Res. 2020 Oct;382(1):135-146. doi: 10.1007/s00441-020-03268-9. Epub 2020 Sep 1.

Abstract

The glial cell line-derived neurotrophic factor (GDNF) and its canonical receptor Ret can signal both in tandem and separately to exert many vital functions in the midbrain dopamine system. It is known that Ret has effects on maintenance, physiology, protection and regeneration in the midbrain dopamine system, with the physiological functions of GDNF still somewhat unclear. Notwithstanding, Ret ligands, such as GDNF, are considered as promising candidates for neuroprotection and/or regeneration in Parkinson's disease, although data from clinical trials are so far inconclusive. In this review, we discuss the current knowledge of GDNF/Ret signaling in the dopamine system in vivo as well as crosstalk with pathology-associated proteins and their signaling in mammals.

Keywords: Cell survival; GDNF; Midbrain dopamine system; Protection; Regeneration; Ret.

Publication types

  • Review

MeSH terms

  • Animals
  • Dopaminergic Neurons / immunology*
  • Glial Cell Line-Derived Neurotrophic Factor / genetics*
  • Humans
  • Proto-Oncogene Proteins c-ret / genetics*
  • Signal Transduction

Substances

  • GDNF protein, human
  • Glial Cell Line-Derived Neurotrophic Factor
  • Proto-Oncogene Proteins c-ret
  • RET protein, human